Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update. Lumos Diagnostics Holdings Ltd. has successfully carried all resolutions at ...

Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update. Lumos Diagnostics Holdings Ltd. has released a presentation providing ...

Discover the Lumos Nyxel helmet's 360° visibility & crash detection for ultimate urban e-bike safety and comfort. Stay ...

As Orchestra Lumos’ concert season continues, the group takes on more fantastic tales. In their upcoming performances on Nov. 9 and 10 in Stamford’s Palace Theatre, they’ll present ...

SAN FRANCISCO, Oct. 30, 2024 /PRNewswire/ -- Lumos, the unified access platform company, today announced it has been named as a winner of the prestigious SINET16 Innovator Award for 2024.

We are excited to help shape Ohio's future by building an internet ready to support its growth, learning, and connection for those in Summit County." Lumos understands fast and reliable internet ...

Lumos Fiber was previously blocked by Lexington County from installing internet cables in the Murraywood neighborhood near Irmo following a water line strike that caused major damage to a ...

Double Point Ventures (DPV) has entered a definitive merger agreement to acquire all outstanding shares of Lumos Pharma for $38m. The transaction also includes a non-transferable contingent value ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gruve, a services provider of innovative AI-driven solutions, is proud to announce the acquisition of Lumos Cloud, a Network Consulting and Training ...

AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Lumos Pharma, Inc. (LUMO) on Thursday reported a loss of $7.5 million in its third quarter. The Austin, Texas-based company said it had a loss of 90 cents per ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Lumos Pharma, Inc. (NASDAQ: LUMO) to Double Point Ventures LLC for $4.25 per share in cash, plus one non ...

Shares of Lumos Pharma were set to rise after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments.